A negative control (NC), miR-320a mimics, and miR-320a inhibitor were obtained from General Biol (Anhui, China) and transfected into Jurkat cells using Lipofectamine® 2000 (Invitrogen, Carlsbad, CA, USA) referring to the manual. Then, a lncRNA Smart Silencer for human LINC00680 was purchased from Ribobio (Guangdong, China). Lipofectamine® 2000 was selected to transfect Jurkat cells with specific plasmids, as described previously. The sense and antisense sequences for the LINC00680 Smart Silencers were as follows: siLINC00680-1, 5′-TCCATTCATTGGGAAATCA-3′ and 5′-AGGGCAGTGTGGAGTGACA-3′; siLINC00680-2, 5′-CATGGACAATATCATAGTT-3′ and 5′-CCTCAGCTCTCCATGGCTCT-3′; and siLINC00680-3, 5′-AGTGTGGAGTGACAGGCACG-3′ and 5′-AAGCATCCATTCATTGGGAA-3′. Cells were cultured in a humidified atmosphere of 5% CO2 at 37°C. Total RNA was then extracted from the transfected cells and analyzed by qRT-PCR to assess the transfection efficiency.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.